Navigation Links
Varian, Inc. Reports First Quarter 2008 Results
Date:1/23/2008

------

December 28, December 29,

2007 2006

------------ ------------

Sales $237,431 $217,938

Cost of sales 130,129 (1) 118,239 (7)

------------ ------------

Gross profit 107,302 99,699

------------ ------------

Operating expenses

Selling, general and administrative 65,980 (2) 61,201 (8)

Research and development 17,180 (3) 15,610 (9)

------------ ------------

Total operating expenses 83,160 76,811

------------ ------------

Operating earnings 24,142 (4) 22,888 (10)

Interest income (expense)

Interest income 1,937 1,269

Interest expense (449) (534)

------------ ------------

Total interest income, net 1,488 735

------------ ------------

Earnings before income taxes 25,630 23,623

Income tax expense 8,046 (5) 8,268 (11)

------------ ------------

Net earnings $17,584 (6) $15,355 (12)

============ ============

Net earnings per diluted share $0.57 (6) $0.49 (12)

============ ============

Diluted shares outstanding 30,900 31,058


'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... and commercializes proprietary technologies and products for advanced microarray ... the fiscal first quarter ended December  31, 2014. All ... (CAD), unless otherwise stated. "During the ... our existing customers and add to our sales pipeline," ...
(Date:2/26/2015)... 2015 Protiviti ( www.protiviti.com ), a global ... Governance Portal , designed to increase the efficiency ... tasks across multiple business units and projects. The Governance ... better align their controls with the COSO ( Committee ... In response to client feedback, Protiviti has also included ...
(Date:2/26/2015)... On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... denying motions for judgment notwithstanding the verdict, a new ...
(Date:2/26/2015)... CLEVELAND , Feb. 26, 2015 BioEnterprise ... biomedical companies have attracted more than $2 billion in ... from local and national investors, strategic sources, state – ... Over half of the $2 billion has been raised ... announcement comes on the heels of the BioEnterprise ...
Breaking Biology Technology:SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4
... 3, 2012  Discovery Laboratories, Inc. (Nasdaq: DSCO ... new standard in respiratory critical care, today reports financial ... The Company will host a conference call this morning ... Key financial information includes: , For ...
... WEST PALM BEACH, Fla., May 2, 2012 BeesFree, Inc. ... that arrests the effects of CCD (Colony Collapse Disorder) ... Prophylaxis Institute (IZS - Istituto Zooprofilattico Sperimentale) will be ... the effectiveness of BeesFree Inc.,s patent-pending technology. ...
... Calif., May 2, 2012 Genomic Health, Inc. (Nasdaq: ... today announced a strategic alliance to use Next Generation ... to the clinical development of OncoMed,s  novel antibody cancer ... OncoMed will provide Genomic Health with breast, prostate, colon ...
Cached Biology Technology:Discovery Labs Reports First Quarter 2012 Financial Results 2Discovery Labs Reports First Quarter 2012 Financial Results 3Discovery Labs Reports First Quarter 2012 Financial Results 4Discovery Labs Reports First Quarter 2012 Financial Results 5Discovery Labs Reports First Quarter 2012 Financial Results 6Discovery Labs Reports First Quarter 2012 Financial Results 7Discovery Labs Reports First Quarter 2012 Financial Results 8Discovery Labs Reports First Quarter 2012 Financial Results 9Discovery Labs Reports First Quarter 2012 Financial Results 10Discovery Labs Reports First Quarter 2012 Financial Results 11The Italian Institute of Prophylaxis against Animal Diseases (IZS) to test effectiveness of BeesFree Inc.'s Technology in Combating Colony Collapse Disorder 2Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing 2Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing 3Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing 4
(Date:2/24/2015)... Feb. 24, 2015 Research and Markets ... of the "Global 2D Gesture Recognition Market ... The analysts forecast the Global 2D Gesture ... 32.12% over the period 2014-2019 The ... sectors is one of the major trends in ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... trying to assert their dominance over their canine or ... the University of Bristol,s Department of Clinical Veterinary Sciences ... and Research . The researchers spent six months ... centre, and reanalysing data from studies of feral dogs, ...
... most extensive study of pollutants in marine mammals, brains ... cocktail of pesticides such as DDTs and PCBs, as ... Eric Montie, the lead author on the ... in Environmental Pollution , performed the research as ...
... end up demented? These days, memory loss is one of ... developing dementia. This is shown in a doctoral thesis at ... Several of the tests previously used to predict which elderly ... longer. The thesis shows that memory loss is the only ...
Cached Biology News:Using 'dominance' to explain dog behavior is old hat 2Skip this cocktail party 2Skip this cocktail party 3Early identification of dementia increasingly difficult 2
Goat polyclonal to DDDDK tag (FITC) ( Abpromise for all tested applications)....
...
DNA fragmentation factor & Inhibitor of CAD...
Component in MasterPure™ Purification Kits...
Biology Products: